Bristol-Myers Squibb to Buy Padlock

24.03.2016 - US drugmaker Bristol-Myers Squibb (BMS) has signed an agreement to acquire Padlock Therapeutics, a privately owned biotechnology firm based at Cambridge, Massachusetts, which...